Multiple-dose exenatide XTEN vs exenatide in type 2 diabetes mellitus.
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2012
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 09 Jun 2012 This trial is still being planned, according to a Diartis Pharmaceuticals media release.
- 16 Feb 2011 This trial is expected to start in 2011.
- 22 Jun 2010 This study is planned to begin in the fourth quarter of 2010, according to a Versartis media release.